Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 5S ribosomal pseudogene 364 (RNA5SP364)** is annotated as a pseudogene related to the 5S ribosomal RNA (5S rRNA) gene[3]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations or lack of regulatory elements necessary for expression[2][3]. RNA5SP364 is classified as a non-coding RNA pseudogene, specifically an rRNA pseudogene, and does not encode a functional product nor participate in canonical ribosome structure or function[2][3]. There is no evidence that RNA5SP364 itself is a therapeutic target, disease-associated gene, biomarker, or involved in drug interactions. While some pseudogenes elsewhere in the genome have been studied for possible regulatory roles or association with disease processes, there is no literature or database evidence to suggest that RNA5SP364 itself has such functional or clinical significance[3][4][6]. **Note:** This entry is "incorrect" as a therapeutic target because RNA5SP364 is not a functional protein, receptor, enzyme, or druggable gene. It is a non-coding, non-functional genomic element without validated biological activity or therapeutic potential[3][2]. The name closely resembles that of true 5S ribosomal RNA; however, functional 5S rRNA (not a pseudogene) is a key part of the ribosome involved in protein synthesis[1][5]. In contrast, RNA5SP364 is a processed pseudogene, not a target[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 364 (RNA5SP364).